<p class="MsoNormal">Hydroxychloroquine is a medication originally developed to prevent and treat malaria, but it is now more commonly used in the management of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. It works by modulating the immune system and reducing inflammation, which helps control disease symptoms. Hydroxychloroquine is typically administered orally in tablet form, and it is often prescribed for long-term use under medical supervision due to the potential for cumulative side effects. It is generally well-tolerated, but patients require regular eye examinations as the drug can, in rare cases, lead to retinal toxicity.

<p class="MsoNormal">During the COVID-19 pandemic, hydroxychloroquine gained global attention as a potential treatment option. However, subsequent clinical studies found no significant benefit for COVID-19 patients and highlighted risks such as heart rhythm disturbances, particularly when combined with other medications. Due to these findings, major health organizations, including the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA), do not recommend its use for COVID-19 outside of clinical trials. Despite the controversy, hydroxychloroquine remains a critical drug in rheumatology when used appropriately.

<p class="MsoNormal"><span style="display: none; mso-hide: all;"> </span>

<p class="MsoNormal">Latest Published Reports by Emergen Research:

<p class="MsoNormal">https://www.emergenresearch.com/industry-report/extended-reality-market

<p class="MsoNormal">https://www.emergenresearch.com/industry-report/5g-chipset-market

<p class="MsoNormal">https://www.emergenresearch.com/industry-report/iot-security-market

<p class="MsoNormal">https://www.emergenresearch.com/industry-report/deep-learning-chip-market

<p class="MsoNormal">https://www.emergenresearch.com/industry-report/sensors-in-internet-of-things-devices-market



<p class="MsoNormal">